EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer

Marta Mendiola iD, Victoria Heredia-Soto, Ignacio Ruz-Caracuel iD, Amparo Baillo iD, Jorge Luis Ramon-Patino iD, Francisco Javier Escudero, Maria Miguel, Alberto Pelaez-Garcia iD, Alicia Hernandez, Jaime Feliu, David Hardisson iD, Andres Redondo iD

International Journal of Molecular Sciences · 23.09.2023 · 24 (19) · 14468

DOI: 10.3390/ijms241914468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.09.2023. Verfasst von Marta Mendiola und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain. Hauptthemen laut MEDLINE: Neoplastic Syndromes, Hereditary, Colorectal Neoplasms, Endometrial Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish State Research Agency, Instituto de Salud Carlos III and the European Regional Development Fund, Instituto de Salud Carlos III (ISCIII).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 20–30% of endometrial carcinomas (EC) are characterized by mismatch repair (MMR) deficiency (dMMR) or microsatellite instability (MSI), and their testing has become part of the routine diagnosis. The aim of this study was to establish and compare the MMR status using various approaches. Immunohistochemistry (IHC), PCR-based MSI, and the detection of defects in the four key MMR genes (MLH1, PMS2, MSH2, and MSH6) via methylation-specific multiplex ligation-dependent probe amplification (MLPA) and targeted next-generation sequencing (NGS) were performed. MSH3 expression was also evaluated. A set of 126 early-stage EC samples were analyzed, 53.2% of which were dMMR and 46.8% of which were proficient MMR (pMMR) as determined using IHC, whereas 69.3% were classified as microsatellite stable, while 8.8% and 21.9% were classified MSI-low (MSI-L) and MSI-high (MSI-H), respectively. In total, 44.3% of the samples showed genetic or epigenetic alterations in one or more genes; MLH1 promoter methylation was the most common event. Although acceptable concordance was observed, there were overall discrepancies between the three testing approaches, mainly associated with the dMMR group. IHC had a better correlation with MMR genomic status than the MSI status determined using PCR. Further studies are needed to establish solid conclusions regarding the best MMR assessment technique for EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Syndromes, HereditaryColorectal NeoplasmsEndometrial NeoplasmsBrain NeoplasmsMicrosatellite InstabilityDNA Mismatch RepairFemaleHumans

Stichwörter der Autor:innen

endometrial carcinomamethylationmicrosatellite instabilitymismatch repair deficiency

Autor:innen und Institutionen

  • Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.
  • Center for Biomedical Research in the Cancer Network (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.
  • Department of Pathology, La Paz University Hospital, 28046 Madrid, Spain.
  • Mathematics Department, Autonomous University of Madrid, 28049 Madrid, Spain.
  • Department of Medical Oncology, La Paz University Hospital, 28046 Madrid, Spain.

ORCID-Profile: Marta Mendiola, Ignacio Ruz-Caracuel, Amparo Baillo, Jorge Luis Ramon-Patino, Alberto Pelaez-Garcia, David Hardisson, Andres Redondo

Förderung

  • Spanish State Research Agency
  • Instituto de Salud Carlos III and the European Regional Development Fund
  • Instituto de Salud Carlos III (ISCIII)
  • European Regional Development Fund ‘A way to achieve Europe’ (FEDER)

Zitieren

APA

Mendiola, M., Heredia-Soto, V., Ruz-Caracuel, I., Baillo, A., Ramon-Patino, J. L., Escudero, F. J., Miguel, M., Pelaez-Garcia, A., Hernandez, A., Feliu, J., Hardisson, D., & Redondo, A. (2023). Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer. International Journal of Molecular Sciences, 24(19), 14468. https://doi.org/10.3390/ijms241914468

Vancouver

Mendiola M, Heredia-Soto V, Ruz-Caracuel I, Baillo A, Ramon-Patino JL, Escudero FJ, et al. Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer. International Journal of Molecular Sciences. 2023;24(19):14468. doi:10.3390/ijms241914468

BibTeX
@article{Mendiola2023,
  author = {Mendiola, Marta and Heredia-Soto, Victoria and Ruz-Caracuel, Ignacio and Baillo, Amparo and Ramon-Patino, Jorge Luis and Escudero, Francisco Javier and Miguel, Maria and Pelaez-Garcia, Alberto and Hernandez, Alicia and Feliu, Jaime and Hardisson, David and Redondo, Andres},
  title = {Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {19},
  pages = {14468},
  doi = {10.3390/ijms241914468}
}
Kostenlos starten →